Metformin × adverse events & safety

SynthesisMedicine2019

Metformin use and prostate cancer risk: A meta-analysis of cohort studies.

Zhaohan Feng et al.PubMed ↗Full text ↗Publisher ↗

What moved togetherboth groups pooled, not the treatment’s effect

Correlation · may be no link

No clear link with adverse events & safety

−3%−20% to +16%

Bigger than 1 in 10 for adverse events & safety

As reported

RR 0.97, 95% CI 0.80–1.16

One number in the abstract

the abstract, start to end

with the risk of prostate cancer (RR 0.97, 95% CI 0.80-1.16, P = .711).

← favours treatmentfavours comparator →
could be chance
Adverse events & safety
RR 0.970.80–1.16
MetforminAdverse events & safety
1 / 3

19 papers cite it

2019
2020
2021
2022
2023
2024
2025
this paperpooled ittrialcites it
Full record →Abstract, authors, funding and every citing paper · PMID 30896668